Economics, externalities and rare disease
Special combined efforts addressing rare diseases should apply economic principles and methods to maximize returns to research and investment. Four opportunities exist: (1) exploiting treatment spillovers; (2) encouraging institutional networking and knowledge-sharing; (3) recognizing shared molecul...
Saved in:
| Main Authors: | Carlisle Ford Runge, James Campbell, Carlisle P. Runge, Reena V. Kartha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Rare |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295000872400019X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reframing risks in rare diseases: economics of networks, spillovers, and scale
by: Carlisle Ford Runge, et al.
Published: (2024-12-01) -
Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs
by: Keiko Yamamoto, et al.
Published: (2025-08-01) -
Orphan diseases — rare but important!
by: article Editorial
Published: (2019-06-01) -
Targeting shared molecular etiologies to accelerate drug development for rare diseases
by: Galliano Zanello, et al.
Published: (2023-06-01) -
Rare disease challenges and potential actions in the Middle East
by: Ahmad Nader Fasseeh, et al.
Published: (2025-02-01)